Preparation, biological & cheminformatics-based assessment of N2,N4-diphenylpyrimidine-2,4-diamine as potential Kinase-targeted antimalarials-Reference-Cited by-同舟云学术

Preparation, biological & cheminformatics-based assessment of N2,N4-diphenylpyrimidine-2,4-diamine as potential Kinase-targeted antimalarials

Published:2021-09 Issue: Volume:46 Page:116348
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Toviwek Borvornwat,Phuangsawai Oraphan,Konsue Adchatawut,Hannongbua Supa,Riley Jennifer,Mutter Nicole,Anderson Mark,Webster Lauren,Hallyburton Irene,Read Kevin D,Gleeson M. Paul

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference52 articles.

1. Trisubstituted thiazoles as potent and selective inhibitors of Plasmodium falciparum protein kinase G (PfPKG);Tsagris;Bioorg Med Chem Lett,2018

2. High-throughput screening of the Plasmodium falciparum cGMP-dependent protein kinase identified a thiazole scaffold which kills erythrocytic and sexual stage parasites;Penzo;Sci Rep,2019

3. Understanding artemisinin resistance;Sibley;Science,2015

4. Spread of Artemisinin Resistance in Plasmodium falciparum Malaria;Ashley;N Engl J Med,2014

5. Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study;Hamilton;Lancet Infect Dis,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation EGFR tyrosine kinase inhibitors to overcome C797S mutation in non-small cell lung cancer (2019–2024);RSC Medicinal Chemistry;2024

2. Characterization of 2,4-Dianilinopyrimidines Against Five P. falciparum Kinases PfARK1, PfARK3, PfNEK3, PfPK9, and PfPKB;ACS Medicinal Chemistry Letters;2023-11-27

3. Correction to “Bespoke Drug Discovery Training for Low-Middle Income Countries”;ACS Medicinal Chemistry Letters;2023-10-05

4. Bespoke Drug Discovery Training for Low-Middle Income Countries;ACS Medicinal Chemistry Letters;2023-07-12

5. PROTACs in the Management of Prostate Cancer;Molecules;2023-04-25